Filing metadata

Accession number
0001104659-21-116068
Form type
Form 3
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Sep 15, 2021
Reporting period
Sep 03, 2021
Description
Initial ownership

Explore SEC Filings Hub